Pharmaron Beijing Co (SZSE:300759) Total Stockholders Equity : ¥12,687 Mil (As of Mar. 2024)

View and export this data going back to 2019. Start your Free Trial

What is Pharmaron Beijing Co Total Stockholders Equity?

Pharmaron Beijing Co's Total Stockholders Equity for the quarter that ended in Mar. 2024 was ¥12,687 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Pharmaron Beijing Co's Book Value per Share for the quarter that ended in Mar. 2024 was ¥7.10. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Pharmaron Beijing Co's Debt-to-Equity for the quarter that ended in Mar. 2024 was 0.65.

Pharmaron Beijing Co Total Stockholders Equity Historical Data

The historical data trend for Pharmaron Beijing Co's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pharmaron Beijing Co Total Stockholders Equity Chart

Pharmaron Beijing Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Stockholders Equity

Get a 7-Day Free Trial

7,767.06

8,870.32

10,129.24

10,548.62

12,556.80

Pharmaron Beijing Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Stockholders Equity	Get a 7-Day Free Trial															10,979.43	11,535.33	11,904.94	12,556.80	12,687.09

Pharmaron Beijing Co (SZSE:300759) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Pharmaron Beijing Co's Book Value per Share for the quarter that ended in Mar. 2024 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(12687.089	-	0)	/	1787.39
	=	7.10

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Pharmaron Beijing Co's Debt-to-Equity for the quarter that ended in Mar. 2024 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(864.465	+	7388.346)	/	12687.089
	=	0.65

Pharmaron Beijing Co Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Pharmaron Beijing Co's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Pharmaron Beijing Co (SZSE:300759) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pharmaron Beijing Co Ltd (SZSE:300759) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

03759:Hong Kong 17Q1:Germany

Address

No. 248 Queen’s Road East, 40th Floor, Dah Sing Financial Centre, Hong Kong, HKG

Website

https://www.pharmaron.com

Pharmaron Beijing Co Ltd is a research and development service company supporting the life science industry. The company offers drug research and development service capabilities, ranging from synthetic, medicinal and analytical chemistry, biology, DMPK, pharmacology, drug safety assessment, radiochemistry and isotopically labelled metabolism, chemical and pharmaceutical development to clinical development. Its operating segment includes Laboratory services; CMC (small molecule CDMO) services; Clinical development services and biologics and CGT services. The company generates maximum revenue from Laboratory services segment.

Executives

Lou Xiao Qiang	Directors, executives
Zheng Bei	Directors, executives

Pharmaron Beijing Co (SZSE:300759) Headlines

No Headlines